Marshall Wace North America’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-63,921
Closed -$15.6M – 1412
2021
Q2
$15.6M Buy
63,921
+60,540
+1,791% +$14.9M 0.06% 299
2021
Q1
$841K Sell
3,381
-113,927
-97% -$27.2M ﹤0.01% 1087
2020
Q4
$27M Buy
117,308
+40,207
+52% +$9.27M 0.12% 196
2020
Q3
$19.6M Sell
77,101
-193,157
-71% -$47.9M 0.13% 189
2020
Q2
$63.7M Buy
270,258
+258,246
+2,150% +$58.9M 0.42% 57
2020
Q1
$2.44M Sell
12,012
-12,426
-51% -$2.71M 0.02% 448
2019
Q4
$5.89M Sell
24,438
-31
-0.1% -$6.83K 0.03% 364
2019
Q3
$4.74M Sell
24,469
-78,752
-76% -$15.1M 0.03% 371
2019
Q2
$19M Buy
+103,221
New +$18.5M 0.12% 155
2018
Q3
– Sell
-37,458
Closed -$6.91M – 904
2018
Q2
$6.91M Buy
+37,458
New +$6.63M 0.04% 430
2017
Q4
– Sell
-19,625
Closed -$3.65M – 1352
2017
Q3
$3.65M Buy
+19,625
New +$3.48M 0.02% 634
2017
Q2
– Sell
-62,084
Closed -$10.2M – 1278
2017
Q1
$10.2M Buy
+62,084
New +$10.3M 0.08% 265
2013
Q4
$20.8M Buy
182,600
+172,662
+1,737% +$19.6M 0.44% 64
2013
Q3
$1.11M Buy
+9,938
New +$1.08M 0.03% 331

Other funds holding AMGN

Marshall Wace North America's AMGN Position: Q3 2021 in Review

Marshall Wace North America sold out of Amgen (AMGN) in Q3 2021, closing a stake of 63,921 shares — an estimated $15.6M sold.

Marshall Wace North America first reported a position in AMGN in Q3 2013 and held it in 14 quarters. The position peaked at $63.7M in Q2 2020. 2,134 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Marshall Wace North America reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 63,921 Amgen shares in Q3 2021, an estimated $15.6M.
  • Marshall Wace North America first reported a position in Amgen in Q3 2013 and held it in 14 quarters.
  • Marshall Wace North America's Amgen position peaked at $63.7M in Q2 2020.
  • 2,134 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.